The Scoliosis Management Market size was USD 3060.51 Million in 2023 and is expected to Reach USD 4188.52 Million by 2031 and grow at a CAGR of 4% over the forecast period of 2024-2031.
The Scoliosis Management Market refers to the market for products and services aimed at diagnosing, treating, and managing scoliosis. Scoliosis is a medical condition characterized by an abnormal curvature of the spine, typically in an "S" or "C" shape. It can affect people of all ages, but it most commonly develops in adolescence. The market for scoliosis management includes various products and services that are used for the diagnosis, monitoring, and treatment of scoliosis. Orthopaedic braces are commonly used to manage scoliosis, especially in children and adolescents with moderate curvature. These braces help in preventing further progression of the spinal curve by providing support and stability to the spine. In severe cases of scoliosis, surgical intervention may be required. Surgical devices such as rods, screws, and hooks are used to correct the spinal curvature and stabilize the spine. These devices are often made from biocompatible materials like titanium or stainless steel. Advanced imaging technologies like X-ray, MRI, and CT scans are used for accurate diagnosis, monitoring, and evaluation of scoliosis. These imaging systems help in assessing the severity of the curvature and assist in planning the appropriate treatment approach. Physical therapy plays a crucial role in managing scoliosis. Therapeutic exercises, stretching, and strengthening programs are designed to improve muscle strength and flexibility, promote spinal alignment, and prevent further progression of the curvature.
.png)
Various tools and technologies are available to monitor and assess the progression of scoliosis. These may include electronic measurement devices, wearable sensors, and computerized systems that provide objective data on spinal curvature and help in tracking the effectiveness of treatment. Additionally, the market may include supportive products like orthopaedic pillows, mattresses, and seating systems designed to provide comfort and proper spinal alignment for individuals with scoliosis. The scoliosis management market is driven by factors such as the increasing prevalence of scoliosis, advancements in diagnostic and treatment technologies, growing awareness about early intervention, and the rise in research and development activities. It is a dynamic and competitive market, with various companies, including medical device manufacturers, orthopaedic clinics, and healthcare providers, offering a range of products and services to meet the needs of individuals with scoliosis.
DRIVERS:
Scoliosis management has been greatly enhanced by improvements in diagnostic imaging, surgical methods, and medical equipment.
The market is being driven by rising infrastructure spending on healthcare.
The growing cost of healthcare, which aids in developing the market's infrastructure, is another important aspect impacting the market's growth rate. Growth and growth of the healthcare sector, particularly in emerging nations, would encourage the adoption and use of cutting-edge medical tools, technology, and medications. The need for scoliosis therapy will consequently rise.
RESTRAIN:
Scoliosis is still poorly understood by both the general public and medical experts.
The main restraining factor in this sector is high treatment costs.
The expense of treating scoliosis, including the price of diagnostic procedures, braces, surgical procedures, and physical therapy, can be high. The cost of therapy can occasionally operate as a barrier, especially for those without access to cheap healthcare or enough insurance coverage. High treatment costs might prevent some solutions from being adopted and have an impact on the market's overall growth.
OPPORTUNITY:
Ongoing developments in imaging technology, surgical procedures, and medical equipment.
Increasing Minimally Invasive Technique Adoption is a big industry potential.
In the treatment of scoliosis, less invasive surgical methods including endoscopic and laparoscopic procedures are becoming more and more common. Potential advantages of these methods include fewer incisions, less tissue stress, shorter hospital stays, and quicker healing. The growing use of less invasive procedures offers chances to enhance patient outcomes and lessen surgical complications.
CHALLENGES:
It may be quite difficult to get patients to comply with scoliosis care procedures like bracing and physical therapy.
Another significant obstacle in this business is psychological and emotional impact.
Scoliosis can significantly affect a person's mental and emotional state, especially in teens. Acceptance of and adherence to therapy may be impacted by challenges with body image, self-esteem, and societal stigma. Better outcomes depend on addressing patients' psychological needs and offering them support throughout their scoliosis therapy journey.
Businesses are under pressure to source more manpower in addition to alternate materials. Since the start of the conflict, Eastern Europe has seen a labor supply shortage, which has once more boosted prices. According to figures from the International Chamber of Shipping (ICS), Russians make up 11.5% (199,123) of the world's shipping workforce, with Ukraine contributing 77,542 (or 6%). Particularly for labor-intensive applications moving away from Eastern Europe, many corporations are increasingly looking into opportunities in Africa and South America. In this field manpower is a basic need to develop the machine. In future the scoliosis management services are more costly.
IMPACT OF ONGOING RECESSION
According to experts, medical device makers are prepared to withstand a downturn in the economy even as they continue to deal with pandemic-related challenges including workforce shortages and enduring supply chain problems. Device makers aren't fully immune to possible recessionary pressures, but the sector should be able to withstand a recession that becomes worse. Effects of the ACA may contribute to more steady procedure volumes. In early 2022, a record number of over 38 million individuals received insurance under the ACA, while 30 million people remained uninsured, down from 47.2 million in the same period the previous year, according to the Department of Health and Human Services. In this database no major impact ongoing recession on Scoliosis Management Markets.
By Type
Spinal system
Orthosis system
By Disease Type
Degenerative scoliosis
Idiopathic scoliosis
Neuromuscular scoliosis
Others
By Age
Pediatrics
Adults
.png)
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSIS
North America: Due to a rise in scoliosis-related hospital visits and procedures, the scoliosis management market in North America is predicted to develop quickly in the years ahead. Nearly 30,000 adolescent scoliosis procedures are performed annually in the United States, according to the CLEAR Scoliosis Institute, which favours the use of scoliosis spinal systems in North America.
Asia Pacific & Europe: The increased incidence of idiopathic scoliosis and government assistance through financing and awareness campaigns are both factors contributing to the market growth for scoliosis management in Europe and the Asia Pacific over the forecast period. The British Scoliosis Research Foundation awards grants to competent specialists for scoliosis research in the U.K., which is anticipated to spur the growth of scoliosis treatment alternatives in Europe.
Some major key players in Scoliosis Management Market are LLC, Aspen Medical Products, Boston Orthotics & Prosthetics, Bauerfeind AG, Chaneco, Fited, Inc., Enovis, Orthotec , Lawall Prosthetics and Orthotics, Horton’s Orthotics & Prosthetics, Optec USA, Inc. and other players.
Convexity Scientific: In 2020, Convexity Scientific purchased Wellinks Inc. The corporation would earn more from this purchase by gaining a bigger portion of the market.
Green Sun Medical: In 2020, For those with teenage idiopathic scoliosis, Green Sun Medical is undertaking pilot research to create a dynamic scoliosis brace.
| Report Attributes | Details |
| Market Size in 2023 | US$ 3060.51 Mn |
| Market Size by 2031 | US$ 4188.52 Mn |
| CAGR | CAGR of 4% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Spinal system, Orthosis system) • By Disease Type (Degenerative scoliosis, Idiopathic scoliosis, Neuromuscular scoliosis, Others) • By Age (Pediatrics, Adults) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | LLC, Aspen Medical Products, Boston Orthotics & Prosthetics, Bauerfeind AG, Chaneco, Fited, Inc., Enovis, Orthotec , Lawall Prosthetics and Orthotics, Horton’s Orthotics & Prosthetics, Optec USA, Inc. |
| Key Drivers | • Scoliosis management has been greatly enhanced by improvements in diagnostic imaging, surgical methods, and medical equipment. |
| Market Restraints | • Scoliosis is still poorly understood by both the general public and medical experts. • The main restraining factor in this sector is high treatment costs. |
Ans: The Scoliosis Management Market is expected to grow at a CAGR of 4.4%.
Ans: The market for Scoliosis Management was worth USD 3060.51 Million in 2023 and is expected to increase to USD 4188.52 Million by 2031.
Ans: The projection period for the Scoliosis Management market is 2022 to 2030.
Ans: The increased use of orthopaedic implants, an increase in scoliosis surgeries, and the development of scoliosis spinal systems with MRI conditions clearance are thought to be the primary drivers of the market for scoliosis management.
Ans: The greatest market share belongs to North America.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Scoliosis Management Market Segmentation, By Type
8.1 Spinal system
8.2 Orthosis system
9. Scoliosis Management Market Segmentation, By Disease Type
9.1 Degenerative scoliosis
9.2 Idiopathic scoliosis
9.3 Neuromuscular scoliosis
9.4 Others
10. Scoliosis Management Market Segmentation, By Age
10.1 Pediatrics
10.2 Adults
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Scoliosis Management Market by Country
11.2.2 North America Scoliosis Management Market by Type
11.2.3 North America Scoliosis Management Market by Disease Type
11.2.4 North America Scoliosis Management Market by Age
11.2.5 USA
11.2.5.1 USA Scoliosis Management Market by Type
11.2.5.2 USA Scoliosis Management Market by Disease Type
11.2.5.3 USA Scoliosis Management Market by Age
11.2.6 Canada
11.2.6.1 Canada Scoliosis Management Market by Type
11.2.6.2 Canada Scoliosis Management Market by Disease Type
11.2.6.3 Canada Scoliosis Management Market by Age
11.2.7 Mexico
11.2.7.1 Mexico Scoliosis Management Market by Type
11.2.7.2 Mexico Scoliosis Management Market by Disease Type
11.2.7.3 Mexico Scoliosis Management Market by Age
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Scoliosis Management Market by Country
11.3.1.2 Eastern Europe Scoliosis Management Market by Type
11.3.1.3 Eastern Europe Scoliosis Management Market by Disease Type
11.3.1.4 Eastern Europe Scoliosis Management Market by Age
11.3.1.5 Poland
11.3.1.5.1 Poland Scoliosis Management Market by Type
11.3.1.5.2 Poland Scoliosis Management Market by Disease Type
11.3.1.5.3 Poland Scoliosis Management Market by Age
11.3.1.6 Romania
11.3.1.6.1 Romania Scoliosis Management Market by Type
11.3.1.6.2 Romania Scoliosis Management Market by Disease Type
11.3.1.6.4 Romania Scoliosis Management Market by Age
11.3.1.7 Turkey
11.3.1.7.1 Turkey Scoliosis Management Market by Type
11.3.1.7.2 Turkey Scoliosis Management Market by Disease Type
11.3.1.7.3 Turkey Scoliosis Management Market by Age
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Scoliosis Management Market by Type
11.3.1.8.2 Rest of Eastern Europe Scoliosis Management Market by Disease Type
11.3.1.8.3 Rest of Eastern Europe Scoliosis Management Market by Age
11.3.2 Western Europe
11.3.2.1 Western Europe Scoliosis Management Market by Country
11.3.2.2 Western Europe Scoliosis Management Market by Type
11.3.2.3 Western Europe Scoliosis Management Market by Disease Type
11.3.2.4 Western Europe Scoliosis Management Market by Age
11.3.2.5 Germany
11.3.2.5.1 Germany Scoliosis Management Market by Type
11.3.2.5.2 Germany Scoliosis Management Market by Disease Type
11.3.2.5.3 Germany Scoliosis Management Market by Age
11.3.2.6 France
11.3.2.6.1 France Scoliosis Management Market by Type
11.3.2.6.2 France Scoliosis Management Market by Disease Type
11.3.2.6.3 France Scoliosis Management Market by Age
11.3.2.7 UK
11.3.2.7.1 UK Scoliosis Management Market by Type
11.3.2.7.2 UK Scoliosis Management Market by Disease Type
11.3.2.7.3 UK Scoliosis Management Market by Age
11.3.2.8 Italy
11.3.2.8.1 Italy Scoliosis Management Market by Type
11.3.2.8.2 Italy Scoliosis Management Market by Disease Type
11.3.2.8.3 Italy Scoliosis Management Market by Age
11.3.2.9 Spain
11.3.2.9.1 Spain Scoliosis Management Market by Type
11.3.2.9.2 Spain Scoliosis Management Market by Disease Type
11.3.2.9.3 Spain Scoliosis Management Market by Age
11.3.2.10 Netherlands
11.3.2.10.1 Netherlands Scoliosis Management Market by Type
11.3.2.10.2 Netherlands Scoliosis Management Market by Disease Type
11.3.2.10.3 Netherlands Scoliosis Management Market by Age
11.3.2.11 Switzerland
11.3.2.11.1 Switzerland Scoliosis Management Market by Type
11.3.2.11.2 Switzerland Scoliosis Management Market by Disease Type
11.3.2.11.3 Switzerland Scoliosis Management Market by Age
11.3.2.1.12 Austria
11.3.2.12.1 Austria Scoliosis Management Market by Type
11.3.2.12.2 Austria Scoliosis Management Market by Disease Type
11.3.2.12.3 Austria Scoliosis Management Market by Age
11.3.2.13 Rest of Western Europe
11.3.2.13.1 Rest of Western Europe Scoliosis Management Market by Type
11.3.2.13.2 Rest of Western Europe Scoliosis Management Market by Disease Type
11.3.2.13.3 Rest of Western Europe Scoliosis Management Market by Age
11.4 Asia-Pacific
11.4.1 Asia-Pacific Scoliosis Management Market by Country
11.4.2 Asia-Pacific Scoliosis Management Market by Type
11.4.3 Asia-Pacific Scoliosis Management Market by Disease Type
11.4.4 Asia-Pacific Scoliosis Management Market by Age
11.4.5 China
11.4.5.1 China Scoliosis Management Market by Type
11.4.5.2 China Scoliosis Management Market by Age
11.4.5.3 China Scoliosis Management Market by Disease Type
11.4.6 India
11.4.6.1 India Scoliosis Management Market by Type
11.4.6.2 India Scoliosis Management Market by Disease Type
11.4.6.3 India Scoliosis Management Market by Age
11.4.7 japan
11.4.7.1 Japan Scoliosis Management Market by Type
11.4.7.2 Japan Scoliosis Management Market by Disease Type
11.4.7.3 Japan Scoliosis Management Market by Age
11.4.8 South Korea
11.4.8.1 South Korea Scoliosis Management Market by Type
11.4.8.2 South Korea Scoliosis Management Market by Disease Type
11.4.8.3 South Korea Scoliosis Management Market by Age
11.4.9 Vietnam
11.4.9.1 Vietnam Scoliosis Management Market by Type
11.4.9.2 Vietnam Scoliosis Management Market by Disease Type
11.4.9.3 Vietnam Scoliosis Management Market by Age
11.4.10 Singapore
11.4.10.1 Singapore Scoliosis Management Market by Type
11.4.10.2 Singapore Scoliosis Management Market by Disease Type
11.4.10.3 Singapore Scoliosis Management Market by Age
11.4.11 Australia
11.4.11.1 Australia Scoliosis Management Market by Type
11.4.11.2 Australia Scoliosis Management Market by Disease Type
11.4.11.3 Australia Scoliosis Management Market by Age
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Scoliosis Management Market by Type
11.4.12.2 Rest of Asia-Pacific Scoliosis Management Market by Disease Type
11.4.12.3 Rest of Asia-Pacific Scoliosis Management Market by Age
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Scoliosis Management Market by Country
11.5.1.2 Middle East Scoliosis Management Market by Type
11.5.1.3 Middle East Scoliosis Management Market by Disease Type
11.5.1.4 Middle East Scoliosis Management Market by Age
11.5.1.5 UAE
11.5.1.5.1 UAE Scoliosis Management Market by Type
11.5.1.5.2 UAE Scoliosis Management Market by Disease Type
11.5.1.5.3 UAE Scoliosis Management Market by Age
11.5.1.6 Egypt
11.5.1.6.1 Egypt Scoliosis Management Market by Type
11.5.1.6.2 Egypt Scoliosis Management Market by Disease Type
11.5.1.6.3 Egypt Scoliosis Management Market by Age
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Scoliosis Management Market by Type
11.5.1.7.2 Saudi Arabia Scoliosis Management Market by Disease Type
11.5.1.7.3 Saudi Arabia Scoliosis Management Market by Age
11.5.1.8 Qatar
11.5.1.8.1 Qatar Scoliosis Management Market by Type
11.5.1.8.2 Qatar Scoliosis Management Market by Disease Type
11.5.1.8.3 Qatar Scoliosis Management Market by Age
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Scoliosis Management Market by Type
11.5.1.9.2 Rest of Middle East Scoliosis Management Market by Disease Type
11.5.1.9.3 Rest of Middle East Scoliosis Management Market by Age
11.5.2 Africa
11.5.2.1 Africa Scoliosis Management Market by Country
11.5.2.2 Africa Scoliosis Management Market by Type
11.5.2.3 Africa Scoliosis Management Market by Disease Type
11.5.2.4 Africa Scoliosis Management Market by Age
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Scoliosis Management Market by Type
11.5.2.5.2 Nigeria Scoliosis Management Market by Disease Type
11.5.2.5.3 Nigeria Scoliosis Management Market by Age
11.5.2.6 South Africa
11.5.2.6.1 South Africa Scoliosis Management Market by Type
11.5.2.6.2 South Africa Scoliosis Management Market by Disease Type
11.5.2.6.3 South Africa Scoliosis Management Market by Age
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Scoliosis Management Market by Type
11.5.2.7.2 Rest of Africa Scoliosis Management Market by Disease Type
11.5.2.7.3 Rest of Africa Scoliosis Management Market by Age
11.6 Latin America
11.6.1 Latin America Scoliosis Management Market by Country
11.6.2 Latin America Scoliosis Management Market by Type
11.6.3 Latin America Scoliosis Management Market by Disease Type
11.6.4 Latin America Scoliosis Management Market by Age
11.6.5 Brazil
11.6.5.1 Brazil America Scoliosis Management Market by Type
11.6.5.2 Brazil America Scoliosis Management Market by Disease Type
11.6.5.3 Brazil America Scoliosis Management Market by Age
11.6.6 Argentina
11.6.6.1 Argentina America Scoliosis Management Market by Type
11.6.6.2 Argentina America Scoliosis Management Market by Disease Type
11.6.6.3 Argentina America Scoliosis Management Market by Age
11.6.7 Colombia
11.6.7.1 Colombia America Scoliosis Management Market by Type
11.6.7.2 Colombia America Scoliosis Management Market by Disease Type
11.6.7.3 Colombia America Scoliosis Management Market by Age
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Scoliosis Management Market by Type
11.6.8.2 Rest of Latin America Scoliosis Management Market by Disease Type
11.6.8.3 Rest of Latin America Scoliosis Management Market by Age
12 Company profile
12.1 Optec USA, Inc.
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Product/Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Aspen Medical Products
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Boston Orthotics & Prosthetics
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Bauerfeind AG
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Chaneco, Fited, Inc.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Enovis
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Orthotec
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Lawall Prosthetics and Orthotics
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Horton’s Orthotics & Prosthetics
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Scoliosis Management Market size was USD 3060.51 Million in 2023 and is expected to Reach USD 4188.52 Million by 2031 and grow at a CAGR of 4% over the forecast period of 2024-2031.
The Hyperphosphatemia Treatment Market size was valued at USD 2.58 Bn in 2022 and is expected to reach USD 3.84 Bn by 2030 with a CAGR of 5.1% over the forecast period of 2023-2030.
The Home Infusion Therapy Market was valued at 47.18 billion in 2023 and is expected to reach 66.59 billion by 2031 and grow at a CAGR of 4.4% during the forecast period of 2024-2031.
The Morphine Market Size was valued at USD 24.48 billion in 2022 and is expected to reach USD 45.31 billion by 2030 and grow at a CAGR of 8% over the forecast period 2023-2030.
The Near-infrared Imaging Market size was estimated USD 2.0 billion in 2022 and is expected to reach USD 2.6 billion by 2030 at a CAGR of 3.8% during the forecast period of 2023-2030.
The eClinical Solutions Market Size was valued at USD 8.33 billion in 2022 and is expected to reach USD 22.94 billion by 2030 and grow at a CAGR of 13.5% over the forecast period 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
